Nab-paclitaxel (Abraxane)
Drug timelines are a Plus or Pro feature.
16 regulatory and trial events tracked for Nab-paclitaxel (Abraxane), covering 2012-03-15 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment [Phase 3]